News
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12
1 Apr 24
News, Price Target, Analyst Ratings
Femasys Q4 EPS $(0.19) Beats $(0.21) Estimate, Sales $213.11K Miss $240.00K Estimate
28 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Chardan Capital Reiterates Buy on Femasys, Maintains $12 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $10 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
21 Feb 24
Biotech, Government, News, Health Care, Financing, General
12 Health Care Stocks Moving In Monday's After-Market Session
19 Feb 24
Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
8 Feb 24
Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 Feb 24
Movers
Press releases
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeedĀ® for the Treatment of Infertility
20 Mar 24
Health Care, Press Releases
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
6 Feb 24
News, Management, Press Releases
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
26 Jan 24
Health Care, Press Releases
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
23 Jan 24
Press Releases